Edwards Lifesciences facing antitrust scrutiny in Europe, NIH chooses Boston as ARPA-H Catalyst Hub

Welcome to the MassDevice Fast Five medtech news podcast, the show that keeps you up-to-date on the latest breakthroughs in medical technology. Here’s what you need to know for today, September 28, 2023. Check out the show notes for links to the stories we discussed today at MassDevice.com/podcast. QT Medical this week announced it raised $12 million in a Series B funding round. Fast Five hosts Sean Whooley and Danielle Kirsh explain what that technology is and how optimistic executives are feeling after the funding round.  BCIs are in the news again this week.  This time, Onward announced the first-in-human implant of a stimulator with BCI technology. Whooley details how the technology works with the BCI and what doctors think after the first implant.  Boston Scientific won an FDA nod for its intravascular ultrasound system. Hear how the system works and how it assists clinicians, as well as some of the features that help support clinicians.  The NIH this week chose Boston as its location for its ARPA-H Catalyst Hub. The Fast Five hosts discuss the details behind this NIH initiative and what organizations will be a part of the hub.  Edwards Lifesciences was revealed as the mystery company facing antitrust scrutiny in Europe, first announced last week. Find out what Edwards' response was to the antitrust investigation.